CADDIE
Commercial- Indications
- Colorectal cancer screening
Company intelligence / Profile preview
Odin Vision has developed cloud-connected artificial intelligence platforms that assist clinicians in real-time during endoscopic procedures. Their flagship product CADDIE received FDA clearance in September 2024 as the first cloud-based AI system for computer-aided polyp detection during colonoscopy. Clinical studies have shown improved polyp characterization and workflow integration. The technology aims to increase early colorectal cancer detection rates by supporting physicians with automated image analysis.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Odin Vision.